TABLE 2

Enzyme kinetics of Abi, D4A, 5α-Abi, and Gal glucuronidation by human liver and the UGT1A4 enzyme

Apparent Kma (μM)Ki (μM)NVmax (pmol/min/mg protein) Clearance (μl/min/mg protein)
Abiraterone
Abi-G1
HLM2.86 ± 0.25446 ± 3440.96 ± 1.1214.38 ± 0.85
UGT1A42.80 ± 0.14645 ± 343.47 ± 6.5415.51 ± 1.55
Abi-G2
HLM1.10 ± 0.12551 ± 2474.17 ± 3.0067.89 ± 10.25
UGT1A40.72 ± 0.10730 ± 21666.75 ± 11.8492.96 ± 3.53
D4A-G
HLM4.52 ± 0.090.93 ± 0.10125.02 ± 27.1827.62 ± 5.49
UGT1A47.40 ± 1.360.81 ± 0.01138.65 ± 11.9919.21 ± 5.15
5α-Abi-G
HLM5.07 ± 0.58446 ± 52206.19 ± 7.2840.79 ± 3.24
UGT1A43.92 ± 0.021712 ± 430222.83 ± 5.8756.82 ± 1.84
Galeterone
Gal-G1
HLM3.52 ± 0.841755 ± 85033.59 ± 1.909.89 ± 2.90
UGT1A44.84 ± 1.201741 ± 39840.08 ± 6.228.39 ± 0.79
Gal-G2
HLM1.03 ± 0.25538 ± 4234.41 ± 0.8034.50 ± 9.10
UGT1A40.61 ± 0.19419 ± 7534.90 ± 5.4458.14 ± 8.80
  • a Results are expressed as mean ± S.D. of triplicate determinations of at least two independent experiments. Kinetic profiles observed were substrate inhibition for Abi-G1, Abi-G2, 5α-Abi-G, Gal-G1 and Gal-G2, and Hill for D4A-G.